These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. [Genetics and clinical types of progressive muscular dystrophy; creatine kinase and myoglobin as biochemical indices of the disease]. Miyoshi K; Kawai H; Sasaki H; Iwaasa M; Yagita M; Ise H; Kondo A; Hiasa M Nihon Rinsho; 1977 Nov; 35(11):3891-6. PubMed ID: 599669 [No Abstract] [Full Text] [Related]
7. Change of serum creatine phosphokinase activity after exercise in Duchenne type of progressive muscular dystrophy. Nakane K Nagoya Med J; 1972 Feb; 17(3):203-16. PubMed ID: 5050757 [No Abstract] [Full Text] [Related]
8. [Value of determination of creatine phosphokinase activity in blood serum for detection of carriers of prograssive muscular dystrophy]. Hetnarska L Neurol Neurochir Pol; 1967; 1(5):583-6. PubMed ID: 6064455 [No Abstract] [Full Text] [Related]
9. [Relationship between serum protein-bound iodine and serum creatine phosphokinase (CPK) activity in hypothyroidism in children]. Saito M Nihon Shonika Gakkai Zasshi; 1967 Feb; 71(2):149-55. PubMed ID: 4168827 [No Abstract] [Full Text] [Related]
10. Letter: Follow-up study of serum-creatine-kinase in carriers of Duchenne muscular dystrophy. Moser H; Vogt J Lancet; 1974 Sep; 2(7881):661-2. PubMed ID: 4137773 [No Abstract] [Full Text] [Related]
11. [Muscular dystrophy and its problems]. Ueda K; Ito T; Nakata T; Ohara T; Matsumoto K Nihon Rinsho; 1968 Sep; 26(9):2184-98. PubMed ID: 5752294 [No Abstract] [Full Text] [Related]
12. Activation of fibrinolysis in muscular dystrophy. Berman PH; Nigro MA; Harris MB; Oski FA Arch Neurol; 1973 Jul; 29(1):65-6. PubMed ID: 4711808 [No Abstract] [Full Text] [Related]
13. Duchenne muscular dystrophy: does serum myoglobin correlate with serum creatine kinase? Kiessling WR; Beckmann R Muscle Nerve; 1981; 4(3):257. PubMed ID: 7242564 [No Abstract] [Full Text] [Related]
15. Serum creatine phosphokinase in muscle disease. An evaluation of two methods of determination and comparison with serum aldolase. Bray GM; Ferrendelli JA Neurology; 1968 May; 18(5):480-4. PubMed ID: 5691174 [No Abstract] [Full Text] [Related]
16. A new screening test for serum creatine phosphokinase. Paterson Y Clin Chim Acta; 1971 Oct; 34(3):373-6. PubMed ID: 5119330 [No Abstract] [Full Text] [Related]
17. [The behavior of serum creatine phosphokinase in myopathies]. Iori E Boll Soc Ital Biol Sper; 1965 Dec; 41(23):1455-6. PubMed ID: 5878343 [No Abstract] [Full Text] [Related]
18. Myoglobinaemia in Duchenne muscular dystrophy patients and carriers: A new adjunct to carrier detection. Adornato BT; Kagen LJ; Engel WK Lancet; 1978 Sep; 2(8088):499-501. PubMed ID: 79868 [TBL] [Abstract][Full Text] [Related]
19. The value of determination of serum creatine phosphokinase activity in detection of carriers of progressive muscular dystrophy. Hetnarska L Pol Med J; 1968; 7(1):224-7. PubMed ID: 5650194 [No Abstract] [Full Text] [Related]